Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation].
Omlin A, Spahn M, Beyer J, Eberli D, Gillessen S, Jochum W, Kueng M, Nitzsche E, Rentsch CA, Roggero E, Schmid HP, Stenner F, Templeton AJ, Wild D, Wyler S, Zwahlen D, Cathomas R. Omlin A, et al. Among authors: rentsch ca. Praxis (Bern 1994). 2018 Sep;107(19):1043-1051. doi: 10.1024/1661-8157/a003054. Praxis (Bern 1994). 2018. PMID: 30227804 Review. German. No abstract available.
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth.
Ruiz C, Oeggerli M, Germann M, Gluderer S, Stocker H, Andreozzi M, Thalmann GN, Cecchini MG, Zellweger T, Stürm S, Koivisto PA, Helin HJ, Gelmann EP, Glass AG, Gasser TC, Terracciano LM, Bachmann A, Wyler S, Bubendorf L, Rentsch CA. Ruiz C, et al. Among authors: rentsch ca. Prostate. 2012 Nov;72(15):1678-87. doi: 10.1002/pros.22521. Epub 2012 Apr 2. Prostate. 2012. PMID: 22473923
Characterization and clinical relevance of ALDHbright populations in prostate cancer.
Le Magnen C, Bubendorf L, Rentsch CA, Mengus C, Gsponer J, Zellweger T, Rieken M, Thalmann GN, Cecchini MG, Germann M, Bachmann A, Wyler S, Heberer M, Spagnoli GC. Le Magnen C, et al. Among authors: rentsch ca. Clin Cancer Res. 2013 Oct 1;19(19):5361-71. doi: 10.1158/1078-0432.CCR-12-2857. Epub 2013 Aug 22. Clin Cancer Res. 2013. PMID: 23969936
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment Registry.
Stenner F, Rothschild SI, Betticher D, Caspar C, Morant R, Popescu R, Rauch D, Huber U, Zenhäusern R, Rentsch C, Cathomas R. Stenner F, et al. Clin Genitourin Cancer. 2017 Aug 24:S1558-7673(17)30244-6. doi: 10.1016/j.clgc.2017.08.003. Online ahead of print. Clin Genitourin Cancer. 2017. PMID: 28958629
Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens.
Servant R, Garioni M, Vlajnic T, Blind M, Pueschel H, Müller DC, Zellweger T, Templeton AJ, Garofoli A, Maletti S, Piscuoglio S, Rubin MA, Seifert H, Rentsch CA, Bubendorf L, Le Magnen C. Servant R, et al. Among authors: rentsch ca. J Pathol. 2021 Aug;254(5):543-555. doi: 10.1002/path.5698. Epub 2021 Jun 2. J Pathol. 2021. PMID: 33934365 Free PMC article.
Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies.
Wetterauer C, Federer-Gsponer JR, Leboutte FDJP, Mona R, Ebbing J, Rentsch CA, Manka L, Seifert HH, Wyler S, Recker F, Kwiatkowski M. Wetterauer C, et al. Among authors: rentsch ca. Urol Int. 2022;106(1):83-89. doi: 10.1159/000517300. Epub 2021 Jul 20. Urol Int. 2022. PMID: 34350895 Free article.
78 results